EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer

Visualitza/ Obre
Data de publicació
2019Autor/a
Roman-Canal, Berta
Moiola, Cristian P.
Gatius Calderó, Sònia
Bonnin, Sarah
Ruiz Miró, Maria
Sierra, José Enrique
Rufas, Maria
González, Esperanza
Gil-Moreno, Antonio
Falcon-Perez, Juan M.
Ponomarenko, Julia
Colás, Eva
Citació recomanada
Roman-Canal, Berta;
Tarragona Foradada, Jordi;
Moiola, Cristian P.;
Gatius Calderó, Sònia;
Bonnin, Sarah;
Ruiz Miró, Maria;
...
Colás, Eva.
(2019)
.
EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer.
Journal of Translational Medicine, 2019, vol. 17, núm. 208.
https://doi.org/10.1186/s12967-019-1954-8.
Metadades
Mostra el registre d'unitat completResum
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related mortality worldwide. Current systematic methods for diagnosing have inherent limitations so development of a minimally-invasive diagnosis, based on the identification of sensitive biomarkers in liquid biopsies could therefore facilitate screening among population at risk. Methods: In this study, we aim to develop a novel approach to identify highly sensitive and specific biomarkers by investigating the use of extracellular vesicles (EVs) isolated from the peritoneal lavage as a source of potential miRNA diagnostic biomarkers. We isolated EVs by ultracentrifugation from 25 ascitic fluids and 25 peritoneal lavages from non-cancer and CRC patients, respectively. Analysis of the expression of EV-associated miRNAs was performed using Taqman OpenArray technology through which we could detect 371 miRNAs. Results: 210 miRNAs were significantly dysregulated (adjusted p value < 0.05 and abs(logFC) ≥ 1). The top-10 miRNAs, which had the AUC value higher than 0.95, were miRNA-199b-5p, miRNA-150-5p, miRNA-29c-5p, miRNA-218-5p, miRNA-99a-3p, miRNA-383-5p, miRNA-199a-3p, miRNA-193a-5p, miRNA-10b-5p and miRNA-181c-5p. Conclusions: This finding opens the avenue to the use of EV-associated miRNA of peritoneal lavages as an untapped source of biomarkers for CRC.
És part de
Journal of Translational Medicine, 2019, vol. 17, núm. 208Projectes de recerca europeus
Col·leccions
Els fitxers de llicència següents estan associats amb aquest element:
Publicacions relacionades
Mostrant elements relacionats per títol, autor i matèria.
-
EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer
Roman-Canal, Berta; Moiola, Cristian P.; Gatius Calderó, Sònia; Bonnin, Sarah; Ruiz Miró, Maria; González, Esperanza; González-Tallada, Xavier; Llordella, Ivanna; Hernández, Isabel; Porcel Pérez, José Manuel; Gil-Moreno, Antonio; Falcon-Perez, Juan M.; Ponomarenko, Julia; Matias-Guiu, Xavier; Colás, Eva (MDPI, 2019)Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for more than 89,000 deaths every year. Mortality is associated with presence of poor prognostic factors at diagnosis, i.e., ... -
EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer
Roman-Canal, Berta; Moiola, Cristian P.; Gatius Calderó, Sònia; Bonnin, Sarah; Ruiz Miró, Maria; González, Esperanza; Ojanguren, Amaia; Recuero, José Luis; Gil-Moreno, Antonio; Falcón-Pérez, Juan M.; Ponomarenko, Julia; Porcel Pérez, José Manuel; Matias-Guiu, Xavier; Colás, Eva (Nature Research, 2019)Lung cancer is the leading cause of cancer-related deaths among men and women in the world, accounting for the 25% of cancer mortality. Early diagnosis is an unmet clinical issue. In this work, we focused to develop a ... -
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
Megino-Luque, Cristina; Moiola, Cristian P.; Molins-Escuder, Clara; López-Gil, Carlos; Gil-Moreno, Antonio; Matias-Guiu, Xavier; Colás, Eva; Eritja Sánchez, Núria (MDPI, 2020-09-24)Endometrial cancer (EC) is the sixth most common cancer in women. A continued number of low-risk EC patients at diagnosis, as well as patients diagnosed with advanced-stage disease, will experience an aggressive disease. ...